美國居民不適用 XM 服務。

Swiss EMS Chemie H1 sales drop 8.1%, cuts 2024 sales guidance



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Swiss EMS Chemie H1 sales drop 8.1%, cuts 2024 sales guidance</title></head><body>

Adds analyst comments in paragraphs 3, 8, 10, share move in paragraph 2

July 12 (Reuters) -Swiss nylon manufacturer EMS Chemie EMSN.S cut its 2024 sales guidance on Friday after reporting weaker-than-expected first-half sales, citing currency effects as the Swiss franc strengthened.

The stock slumped 6.5% as of 0750 GMT, heading for its worst day since April.

Net sales in the first half of the year declined 8.1% to 1.09 billion Swiss francs ($1.22 billion), EMS said, which, according to Vontobel analyst Sibylle Bischofberger did not meet consensus estimates.

The company said it now expects its 2024 net sales to fall slightly, after previously forecasting net sales in line with the 2023 figure of 2.19 billion Swiss francs.

EMS Chemie forecast the economic environment would continue to be difficult in 2024, adding there was no sign of any growth impulse in global manufacturing.

"New political regulations and penal customs duties are also unsettling consumer confidence and hampering companies' investment decisions," the company said in a statement.

The mood in the European chemical industry remains cautious as the sector has long been suffering from weak demand and high production costs.

Bischofberger said the company's specialty product portfolio is less affected by the challenging situation, but added that EMS Chemie "cannot escape market developments".

The company reaffirmed its full-year earnings before interest and tax (EBIT) outlook and still sees a figure slightly above previous year's 493 million francs.

Analysts said EMS Chemie's margins had improved significantly, helped by higher volumes and after expanding in Asia, America and Europe.

EMS Chemie kicked off the earnings reporting season for European chemical makers, with peers such as Clariant CLN.S, K+S SDFGn.DE and Givaudan GIVN.S set to report their quarterly results in the coming weeks.


($1 = 0.8958 Swiss francs)



($1 = 0.8955 Swiss francs)



Reporting by Marta Frackowiak and Bartosz Dabrowski in Gdansk
Editing by Ludwig Burger and Sharon Singleton

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明